Cargando…
Enhanced validation of antibodies for research applications
There is a need for standardized validation methods for antibody specificity and selectivity. Recently, five alternative validation pillars were proposed to explore the specificity of research antibodies using methods with no need for prior knowledge about the protein target. Here, we show that thes...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175901/ https://www.ncbi.nlm.nih.gov/pubmed/30297845 http://dx.doi.org/10.1038/s41467-018-06642-y |
_version_ | 1783361591059677184 |
---|---|
author | Edfors, Fredrik Hober, Andreas Linderbäck, Klas Maddalo, Gianluca Azimi, Alireza Sivertsson, Åsa Tegel, Hanna Hober, Sophia Szigyarto, Cristina Al-Khalili Fagerberg, Linn von Feilitzen, Kalle Oksvold, Per Lindskog, Cecilia Forsström, Björn Uhlen, Mathias |
author_facet | Edfors, Fredrik Hober, Andreas Linderbäck, Klas Maddalo, Gianluca Azimi, Alireza Sivertsson, Åsa Tegel, Hanna Hober, Sophia Szigyarto, Cristina Al-Khalili Fagerberg, Linn von Feilitzen, Kalle Oksvold, Per Lindskog, Cecilia Forsström, Björn Uhlen, Mathias |
author_sort | Edfors, Fredrik |
collection | PubMed |
description | There is a need for standardized validation methods for antibody specificity and selectivity. Recently, five alternative validation pillars were proposed to explore the specificity of research antibodies using methods with no need for prior knowledge about the protein target. Here, we show that these principles can be used in a streamlined manner for enhanced validation of research antibodies in Western blot applications. More than 6,000 antibodies were validated with at least one of these strategies involving orthogonal methods, genetic knockdown, recombinant expression, independent antibodies, and capture mass spectrometry analysis. The results show a path forward for efforts to validate antibodies in an application-specific manner suitable for both providers and users. |
format | Online Article Text |
id | pubmed-6175901 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-61759012018-10-11 Enhanced validation of antibodies for research applications Edfors, Fredrik Hober, Andreas Linderbäck, Klas Maddalo, Gianluca Azimi, Alireza Sivertsson, Åsa Tegel, Hanna Hober, Sophia Szigyarto, Cristina Al-Khalili Fagerberg, Linn von Feilitzen, Kalle Oksvold, Per Lindskog, Cecilia Forsström, Björn Uhlen, Mathias Nat Commun Article There is a need for standardized validation methods for antibody specificity and selectivity. Recently, five alternative validation pillars were proposed to explore the specificity of research antibodies using methods with no need for prior knowledge about the protein target. Here, we show that these principles can be used in a streamlined manner for enhanced validation of research antibodies in Western blot applications. More than 6,000 antibodies were validated with at least one of these strategies involving orthogonal methods, genetic knockdown, recombinant expression, independent antibodies, and capture mass spectrometry analysis. The results show a path forward for efforts to validate antibodies in an application-specific manner suitable for both providers and users. Nature Publishing Group UK 2018-10-08 /pmc/articles/PMC6175901/ /pubmed/30297845 http://dx.doi.org/10.1038/s41467-018-06642-y Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Edfors, Fredrik Hober, Andreas Linderbäck, Klas Maddalo, Gianluca Azimi, Alireza Sivertsson, Åsa Tegel, Hanna Hober, Sophia Szigyarto, Cristina Al-Khalili Fagerberg, Linn von Feilitzen, Kalle Oksvold, Per Lindskog, Cecilia Forsström, Björn Uhlen, Mathias Enhanced validation of antibodies for research applications |
title | Enhanced validation of antibodies for research applications |
title_full | Enhanced validation of antibodies for research applications |
title_fullStr | Enhanced validation of antibodies for research applications |
title_full_unstemmed | Enhanced validation of antibodies for research applications |
title_short | Enhanced validation of antibodies for research applications |
title_sort | enhanced validation of antibodies for research applications |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175901/ https://www.ncbi.nlm.nih.gov/pubmed/30297845 http://dx.doi.org/10.1038/s41467-018-06642-y |
work_keys_str_mv | AT edforsfredrik enhancedvalidationofantibodiesforresearchapplications AT hoberandreas enhancedvalidationofantibodiesforresearchapplications AT linderbackklas enhancedvalidationofantibodiesforresearchapplications AT maddalogianluca enhancedvalidationofantibodiesforresearchapplications AT azimialireza enhancedvalidationofantibodiesforresearchapplications AT sivertssonasa enhancedvalidationofantibodiesforresearchapplications AT tegelhanna enhancedvalidationofantibodiesforresearchapplications AT hobersophia enhancedvalidationofantibodiesforresearchapplications AT szigyartocristinaalkhalili enhancedvalidationofantibodiesforresearchapplications AT fagerberglinn enhancedvalidationofantibodiesforresearchapplications AT vonfeilitzenkalle enhancedvalidationofantibodiesforresearchapplications AT oksvoldper enhancedvalidationofantibodiesforresearchapplications AT lindskogcecilia enhancedvalidationofantibodiesforresearchapplications AT forsstrombjorn enhancedvalidationofantibodiesforresearchapplications AT uhlenmathias enhancedvalidationofantibodiesforresearchapplications |